Skip to main content
Top
Published in: Current Cardiology Reports 8/2015

01-08-2015 | Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Management of Ventricular Arrhythmias in Patients with Mechanical Ventricular Support Devices

Authors: Chris Healy, Juan F. Viles-Gonzalez, Frederic Sacher, James O. Coffey, Andre d’Avila

Published in: Current Cardiology Reports | Issue 8/2015

Login to get access

Abstract

The use of mechanical ventricular support devices in the management of patients with advanced heart failure continues to increase. These devices have been shown to prolong life as a destination therapy and to increase survival when used as a bridge to transplantation. However, they are associated with a high rate of complications, including bleeding, infection, device malfunction, and ventricular arrhythmias (VAs). The mechanical support provided by the device typically allows for VAs to be well tolerated in the acute setting, though there are numerous long-term complications related to VAs such as ventricular remodeling, right ventricular failure in patients with left ventricular assist devices, and possibly increased mortality. Controversy exists as to the appropriate role of implantable cardioverter defibrillators in these patients. This review will focus on the management options available for patients with mechanical ventricular support devices and VAs.
Literature
1.
go back to reference Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.PubMedCrossRef Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.PubMedCrossRef
2.
go back to reference Slaughter M, Rogers J, Milano C, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular device. N Engl J Med. 2009;361:2241–51.PubMedCrossRef Slaughter M, Rogers J, Milano C, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular device. N Engl J Med. 2009;361:2241–51.PubMedCrossRef
3.
go back to reference Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. Heart Lung Transplant. 2013;32(2):141–56.CrossRef Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. Heart Lung Transplant. 2013;32(2):141–56.CrossRef
4.
go back to reference Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005;45:1428–34.PubMedCrossRef Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005;45:1428–34.PubMedCrossRef
5.
go back to reference Refaat M, Chemaly E, Lebeche D, Gwathmey JK, Hajjar RJ. Ventricular arrhythmias after left ventricular assist device implantation. PACE. 2008;31:1246–52.PubMedCentralPubMedCrossRef Refaat M, Chemaly E, Lebeche D, Gwathmey JK, Hajjar RJ. Ventricular arrhythmias after left ventricular assist device implantation. PACE. 2008;31:1246–52.PubMedCentralPubMedCrossRef
6.
go back to reference Cantillon DJ, Tarakji KG, Kumbhani DJ, Smedira NC, Starling RC, Wilkoff BL. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm. 2010;7:466–71.PubMedCrossRef Cantillon DJ, Tarakji KG, Kumbhani DJ, Smedira NC, Starling RC, Wilkoff BL. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm. 2010;7:466–71.PubMedCrossRef
7.
go back to reference Oswald H, Schultz-Wildelau C, Gardiwal A, Lusebrink U, Konig T, Meyer A, et al. Implantable defibrillator therapy for ventricular tachycardia in left ventricular assist device patients. Eur J Heart Fail. 2010;12:593–9.PubMedCrossRef Oswald H, Schultz-Wildelau C, Gardiwal A, Lusebrink U, Konig T, Meyer A, et al. Implantable defibrillator therapy for ventricular tachycardia in left ventricular assist device patients. Eur J Heart Fail. 2010;12:593–9.PubMedCrossRef
8.
go back to reference Bedi M, Kormos R, Winowich S, McNamara D, Mathier M, Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99:1151–3.PubMedCrossRef Bedi M, Kormos R, Winowich S, McNamara D, Mathier M, Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99:1151–3.PubMedCrossRef
9.
go back to reference Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen P, Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant. 2009;28:733–5.PubMedCrossRef Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen P, Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant. 2009;28:733–5.PubMedCrossRef
10.
go back to reference Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland Jr JC, et al. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant. 2010;29:771–6.PubMedCrossRef Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland Jr JC, et al. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant. 2010;29:771–6.PubMedCrossRef
11.
go back to reference Hasin T, Marmor Y, Kremers W, Topilsky Y, Severson CJ, Schirger JA, et al. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol. 2013;61(2):153–63.PubMedCrossRef Hasin T, Marmor Y, Kremers W, Topilsky Y, Severson CJ, Schirger JA, et al. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol. 2013;61(2):153–63.PubMedCrossRef
12.
go back to reference Yuan N, Arnaoutakis GJ, George TJ, Allen JG, Ju DG, Schaffer JM, et al. The spectrum of complications following left ventricular assist device placement. J Card Surg. 2012;27(5):630–8.PubMedCrossRef Yuan N, Arnaoutakis GJ, George TJ, Allen JG, Ju DG, Schaffer JM, et al. The spectrum of complications following left ventricular assist device placement. J Card Surg. 2012;27(5):630–8.PubMedCrossRef
13.
go back to reference Garan AR, Yuzefpolskaya M, Colombo PC, Morrow JP, Te-Frey R, Dano D, et al. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? J Am Coll Cardiol. 2013;61(25):2542–50.PubMedCrossRef Garan AR, Yuzefpolskaya M, Colombo PC, Morrow JP, Te-Frey R, Dano D, et al. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? J Am Coll Cardiol. 2013;61(25):2542–50.PubMedCrossRef
14.
go back to reference Drakos SG, Terrovitis JV, Nanas JN, Charitos EI, Ntalianis AS, Malliaras KG, et al. Reverse electrophysiologic remodeling after cardiac mechanical unloading for end-stage nonischemic cardiomyopathy. Ann Thorac Surg. 2011;91:764–9.PubMedCrossRef Drakos SG, Terrovitis JV, Nanas JN, Charitos EI, Ntalianis AS, Malliaras KG, et al. Reverse electrophysiologic remodeling after cardiac mechanical unloading for end-stage nonischemic cardiomyopathy. Ann Thorac Surg. 2011;91:764–9.PubMedCrossRef
15.
go back to reference Mufti HN, Rajda M, Legare JF. Arrhythmogenic right ventricular cardiomyopathy: use of a left ventricular assist device as a bridge to transplantation? J Artif Organs. 2013;16(4):498–500.PubMedCrossRef Mufti HN, Rajda M, Legare JF. Arrhythmogenic right ventricular cardiomyopathy: use of a left ventricular assist device as a bridge to transplantation? J Artif Organs. 2013;16(4):498–500.PubMedCrossRef
16.
go back to reference Oz MC, Rose EA, Slater J, Kuiper JJ, Catanese KA, Levin HR. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol. 1994;24:1688–91.PubMedCrossRef Oz MC, Rose EA, Slater J, Kuiper JJ, Catanese KA, Levin HR. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol. 1994;24:1688–91.PubMedCrossRef
17.
go back to reference Sims DB, Rosner G, Uriel N, González-Costello J, Ehlert FA, Jorde UP. Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device. Pacing Clin Electrophysiol. 2012;35:e144–8.PubMedCrossRef Sims DB, Rosner G, Uriel N, González-Costello J, Ehlert FA, Jorde UP. Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device. Pacing Clin Electrophysiol. 2012;35:e144–8.PubMedCrossRef
18.
go back to reference Boilson BA, Durham LA, Park SJ. Ventricular fibrillation in an ambulatory patient supported by a left ventricular assist device: highlighting the ICD controversy. ASAIO J. 2012;58:170–3.PubMed Boilson BA, Durham LA, Park SJ. Ventricular fibrillation in an ambulatory patient supported by a left ventricular assist device: highlighting the ICD controversy. ASAIO J. 2012;58:170–3.PubMed
19.
go back to reference Busch MC, Haap M, Kristen A, Haas CS. Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assist device. Ann Emerg Med. 2011;57:25–8.PubMedCrossRef Busch MC, Haap M, Kristen A, Haas CS. Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assist device. Ann Emerg Med. 2011;57:25–8.PubMedCrossRef
20.
go back to reference Fasseas P, Kutalek SP, Kantharia BK. Prolonged sustained ventricular fibrillation without loss of consciousness in patients supported by a left ventricular assist device. Cardiology. 2002;97:210–3.PubMedCrossRef Fasseas P, Kutalek SP, Kantharia BK. Prolonged sustained ventricular fibrillation without loss of consciousness in patients supported by a left ventricular assist device. Cardiology. 2002;97:210–3.PubMedCrossRef
21.
go back to reference Salzberg SP, Lachat ML, Zünd G, Turina MI. Left ventricular assist device (LVAD) enables survival during 7 h of sustained ventricular fibrillation. Eur J Cardiothorac Surg. 2004;26:444–6.PubMedCrossRef Salzberg SP, Lachat ML, Zünd G, Turina MI. Left ventricular assist device (LVAD) enables survival during 7 h of sustained ventricular fibrillation. Eur J Cardiothorac Surg. 2004;26:444–6.PubMedCrossRef
22.
go back to reference Nishimura M, Ogiwara M, Ishikawa M, et al. Fifteen-month circulatory support for sustained ventricular fibrillation by left ventricular assist device. J Thorac Cardiovasc Surg. 2003;126:1190.PubMedCrossRef Nishimura M, Ogiwara M, Ishikawa M, et al. Fifteen-month circulatory support for sustained ventricular fibrillation by left ventricular assist device. J Thorac Cardiovasc Surg. 2003;126:1190.PubMedCrossRef
23.
go back to reference Raasch H, Jensen BC, Chang PP, Mounsey JP, Gehi AK, Chung EH, et al. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012;164(3):373–8.PubMedCrossRef Raasch H, Jensen BC, Chang PP, Mounsey JP, Gehi AK, Chung EH, et al. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012;164(3):373–8.PubMedCrossRef
24.
25.
go back to reference Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105:589–94.PubMedCrossRef Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105:589–94.PubMedCrossRef
26.
go back to reference Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009–17.PubMedCentralPubMedCrossRef Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009–17.PubMedCentralPubMedCrossRef
27.
go back to reference Cleveland Jr JC, Naftel DC, Reece TB, Murray M, Antaki J, Pagani FD, et al. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database. J Heart Lung Transplant. 2011;30(8):862–9.PubMed Cleveland Jr JC, Naftel DC, Reece TB, Murray M, Antaki J, Pagani FD, et al. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database. J Heart Lung Transplant. 2011;30(8):862–9.PubMed
28.
go back to reference Aissaoui N, Morshuis M, Paluszkiewicz L, Lauenroth V, Börgermann J, Gummert J. Comparison of biventricular and left ventricular assist devices for the management of severe right ventricular dysfunction in patients with end-stage heart failure. ASAIO J. 2014;60:400–6.PubMedCrossRef Aissaoui N, Morshuis M, Paluszkiewicz L, Lauenroth V, Börgermann J, Gummert J. Comparison of biventricular and left ventricular assist devices for the management of severe right ventricular dysfunction in patients with end-stage heart failure. ASAIO J. 2014;60:400–6.PubMedCrossRef
29.
go back to reference Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NAM, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6–75.PubMedCrossRef Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NAM, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6–75.PubMedCrossRef
30.
go back to reference Cabanelas N, Oliveira M, Nogueira da Silva M, Cunha P, Valente B, Lousinha A, et al. The proarrhythmic effect of cardiac resynchronization therapy: an issue that should be borne in mind. Rev Port Cardiol. 2014;33(5):309.e1–7. Cabanelas N, Oliveira M, Nogueira da Silva M, Cunha P, Valente B, Lousinha A, et al. The proarrhythmic effect of cardiac resynchronization therapy: an issue that should be borne in mind. Rev Port Cardiol. 2014;33(5):309.e1–7.
31.
go back to reference Kutyifa V, Zareba W, McNitt S, Singh J, Hall WJ, Polonsky S, et al. Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial. Eur Heart J. 2013;34(3):184–90.PubMedCrossRef Kutyifa V, Zareba W, McNitt S, Singh J, Hall WJ, Polonsky S, et al. Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial. Eur Heart J. 2013;34(3):184–90.PubMedCrossRef
32.
go back to reference Gopinathannair R, Birks EJ, Trivedi JR, McCants KC, Sutton BS, Deam AG, et al. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous flow left ventricular assist devices. J Card Fail. 2015;21:226–32. S1071-9164(14)01348-7.PubMedCrossRef Gopinathannair R, Birks EJ, Trivedi JR, McCants KC, Sutton BS, Deam AG, et al. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous flow left ventricular assist devices. J Card Fail. 2015;21:226–32. S1071-9164(14)01348-7.PubMedCrossRef
33.
34.
go back to reference Steinberg JS, Martins J, Sadanandan S, et al. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) study. Am Heart J. 2001;142:520–9.PubMedCrossRef Steinberg JS, Martins J, Sadanandan S, et al. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) study. Am Heart J. 2001;142:520–9.PubMedCrossRef
35.
go back to reference Farre J, Romero J, Rubio JM, et al. Amiodarone and “primary” prevention of sudden death: critical review of a decade of clinical trials. Am J Cardiol. 1999;83:55D–63.PubMedCrossRef Farre J, Romero J, Rubio JM, et al. Amiodarone and “primary” prevention of sudden death: critical review of a decade of clinical trials. Am J Cardiol. 1999;83:55D–63.PubMedCrossRef
36.
go back to reference Cleland JG, Ghosh J, Freemantle N, et al. Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail. 2004;6:501–8.PubMedCrossRef Cleland JG, Ghosh J, Freemantle N, et al. Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail. 2004;6:501–8.PubMedCrossRef
37.
go back to reference Lok SI, Martina JR, Hesselink T, Rodermans BF, Hulstein N, Winkens B, et al. Single-centre experience of 85 patients with a continuous-flow left ventricular assist device: clinical practice and outcome after extended support. Eur J Cardiothorac Surg. 2013;44(3):e233–8.PubMedCrossRef Lok SI, Martina JR, Hesselink T, Rodermans BF, Hulstein N, Winkens B, et al. Single-centre experience of 85 patients with a continuous-flow left ventricular assist device: clinical practice and outcome after extended support. Eur J Cardiothorac Surg. 2013;44(3):e233–8.PubMedCrossRef
38.
go back to reference Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33:414–9.PubMedCrossRef Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33:414–9.PubMedCrossRef
39.•
go back to reference Enriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2013;6(4):668–74. This study demonstrated no significant association between the presence of an ICD and survival among patients with contemporary, continuous-flow LVADs.PubMedCrossRef Enriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2013;6(4):668–74. This study demonstrated no significant association between the presence of an ICD and survival among patients with contemporary, continuous-flow LVADs.PubMedCrossRef
40.
go back to reference Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26):2657–65.PubMedCentralPubMedCrossRef Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26):2657–65.PubMedCentralPubMedCrossRef
41.
go back to reference Dandamudi G, Ghumman WS, Das MK, Miller JM. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Heart Rhythm. 2007;4(9):1165–9.PubMedCrossRef Dandamudi G, Ghumman WS, Das MK, Miller JM. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Heart Rhythm. 2007;4(9):1165–9.PubMedCrossRef
42.
go back to reference Osaki S, Alberte C, Murray MA, Brahmbhatt RD, Johnson MR, Edwards NM, et al. Successful radiofrequency ablation therapy for intractable ventricular tachycardia with a ventricular assist device. J Heart Lung Transplant. 2008;27:353–6.PubMedCrossRef Osaki S, Alberte C, Murray MA, Brahmbhatt RD, Johnson MR, Edwards NM, et al. Successful radiofrequency ablation therapy for intractable ventricular tachycardia with a ventricular assist device. J Heart Lung Transplant. 2008;27:353–6.PubMedCrossRef
43.
go back to reference Lü F, Eckman PM, Liao KK, Apostolidou I, John R, Chen T, et al. Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support. Int J Cardiol. 2013;168:3859–65.PubMedCrossRef Lü F, Eckman PM, Liao KK, Apostolidou I, John R, Chen T, et al. Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support. Int J Cardiol. 2013;168:3859–65.PubMedCrossRef
44.
go back to reference Garan AR, Iyer V, Whang W, Mody KP, Yuzefpolskaya M, Colombo PC, et al. Catheter ablation for ventricular tachyarrhythmias in patients supported by continuous-flow left ventricular assist devices. ASAIO J. 2014;60:311–6.PubMedCrossRef Garan AR, Iyer V, Whang W, Mody KP, Yuzefpolskaya M, Colombo PC, et al. Catheter ablation for ventricular tachyarrhythmias in patients supported by continuous-flow left ventricular assist devices. ASAIO J. 2014;60:311–6.PubMedCrossRef
45.
go back to reference Herweg B, Ilercil A, Kristof-Kuteyeva O, Rinde-Hoffman D, Caldeira C, Mangar D, et al. Clinical observations and outcome of ventricular tachycardia ablation in patients with left ventricular assist devices. Pacing Clin Electrophysiol. 2012;35:1377–83.PubMedCrossRef Herweg B, Ilercil A, Kristof-Kuteyeva O, Rinde-Hoffman D, Caldeira C, Mangar D, et al. Clinical observations and outcome of ventricular tachycardia ablation in patients with left ventricular assist devices. Pacing Clin Electrophysiol. 2012;35:1377–83.PubMedCrossRef
46.••
go back to reference Cantillon DJ, Bianco C, Wazni OM, Kanj M, Smedira NG, Wilkoff BL, et al. Electrophysiologic characteristics and catheter ablation of ventricular tachyarrhythmias among patients with heart failure on ventricular assist device support. Heart Rhythm. 2012;9:859–64. This study is the largest study to date, demonstrating the safety and feasibility of catheter ablation for the treatment of recurrent ventricular tachyarrhythmias in patients with VADs.PubMedCrossRef Cantillon DJ, Bianco C, Wazni OM, Kanj M, Smedira NG, Wilkoff BL, et al. Electrophysiologic characteristics and catheter ablation of ventricular tachyarrhythmias among patients with heart failure on ventricular assist device support. Heart Rhythm. 2012;9:859–64. This study is the largest study to date, demonstrating the safety and feasibility of catheter ablation for the treatment of recurrent ventricular tachyarrhythmias in patients with VADs.PubMedCrossRef
47.
go back to reference Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Bergin JD, Mahapatra S, et al. Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias. J Thorac Cardiovasc Surg. 2013;145:1207–13.PubMedCentralPubMedCrossRef Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Bergin JD, Mahapatra S, et al. Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias. J Thorac Cardiovasc Surg. 2013;145:1207–13.PubMedCentralPubMedCrossRef
48.
go back to reference Dandel M, Weng Y, Siniawski H, Stepanenko A, Krabatsch T, Potapov E, et al. Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices. Eur Heart J. 2011;32(9):1148–60.PubMedCentralPubMedCrossRef Dandel M, Weng Y, Siniawski H, Stepanenko A, Krabatsch T, Potapov E, et al. Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices. Eur Heart J. 2011;32(9):1148–60.PubMedCentralPubMedCrossRef
49.
go back to reference Yildirim Y, Pecha S, Reichenspurner H, Deuse T. Mechanically induced ventricular tachycardia by the HeartWare ventricular assist device. ASAIO J. 2014;60:124–6.PubMedCrossRef Yildirim Y, Pecha S, Reichenspurner H, Deuse T. Mechanically induced ventricular tachycardia by the HeartWare ventricular assist device. ASAIO J. 2014;60:124–6.PubMedCrossRef
Metadata
Title
Management of Ventricular Arrhythmias in Patients with Mechanical Ventricular Support Devices
Authors
Chris Healy
Juan F. Viles-Gonzalez
Frederic Sacher
James O. Coffey
Andre d’Avila
Publication date
01-08-2015
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 8/2015
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-015-0617-5

Other articles of this Issue 8/2015

Current Cardiology Reports 8/2015 Go to the issue

Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Pacing the Heart with Genes: Recent Progress in Biological Pacing

Nuclear Cardiology (V Dilsizian, Section Editor)

Prognostic Significance of Imaging Myocardial Sympathetic Innervation

Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Non-invasive Mapping of Cardiac Arrhythmias